15.02.2013 Views

world cancer report - iarc

world cancer report - iarc

world cancer report - iarc

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Fig. 4.48 Women at a clinic in India participating<br />

in a study of early detection of cervical <strong>cancer</strong>.<br />

the liquid-based method seems to result<br />

in more slides being classified as having<br />

low-grade squamous epithelial lesions or<br />

higher, which were classified as having<br />

less severe disease by conventional<br />

smears, than the reverse situation. The<br />

difference in cost between liquid-based<br />

and conventional cytology is unclear<br />

because of substantial uncertainty about<br />

the relative effectiveness of these two<br />

approaches[13].<br />

It has been suggested that improvements<br />

in the detection of dyskaryosis (abnormal<br />

changes in cell nuclei) using extended tip<br />

plastic spatulas instead of the traditional<br />

wooden Ayre’s spatula would be of<br />

approximately similar magnitude to the<br />

improvements which might result from<br />

replacing conventional cytology with<br />

liquid-based methods [14]. Automated<br />

cytology reading systems are under development<br />

and some health economic evaluation<br />

has been carried out.<br />

In view of the importance of HPV in the<br />

etiology of cervical <strong>cancer</strong>, HPV testing to<br />

allow women to be classified as high-risk<br />

HPV-positive (displaying HPV types associated<br />

with an increased risk of cervical<br />

neoplasia) or negative (otherwise) could<br />

be used as an adjunct to cytological<br />

smear tests. However, the possible value<br />

of HPV testing in the triage of women with<br />

low-grade abnormalities is uncertain.<br />

Alternatives to the Pap smear<br />

HPV testing<br />

HPV testing may be used for primary<br />

screening. In developed countries, most<br />

attention has been focused on HPV testing<br />

as an adjunct to cytological screening<br />

170 Prevention and screening<br />

(see above), in part because of ethical and<br />

medico-legal problems which might ensue<br />

in conducting a randomized trial which<br />

would involve withdrawal of the offer of<br />

cytological screening from the group<br />

assigned to be offered HPV testing. This<br />

would not be the case for populations in<br />

which Pap testing has not been introduced,<br />

notably in developing countries.<br />

The major issues in relation to such use of<br />

HPV testing have been the cost of the test<br />

itself and its relatively poor specificity<br />

[15,16]. Poor specificity results in followup<br />

for women without cervical disease,<br />

incurring costs which may be more than<br />

the society can afford. In both developed<br />

and developing countries, the development<br />

of primary screening based on HPV<br />

tests might be rendered obsolete by mass<br />

HPV vaccination (Human papillomavirus<br />

vaccination, p148).<br />

Visual inspection<br />

Unaided visual inspection of the cervix by<br />

nurses and other non-medical health<br />

workers, also known as “down-staging”,<br />

has been proposed for developing countries<br />

which lack the laboratory facilities or<br />

resources to implement cytological<br />

screening [17]. Women with abnormal<br />

findings require further investigation,<br />

which entails a cytological test if appropriate<br />

facilities are available, or specialist<br />

medical examination if no cytology services<br />

are available.<br />

In view of the unsatisfactory performance<br />

of unaided visual inspection, consideration<br />

has been given to aiding naked-eye<br />

visual inspection by impregnating the<br />

cervix with 3-4% freshly prepared acetic<br />

acid to detect acetowhite areas (Fig.<br />

4.47). This screening approach is known<br />

as visual inspection with acetic acid (VIA)<br />

(synonyms are cervicoscopy and direct<br />

visual inspection). In studies in China,<br />

India, South Africa and Zimbabwe, visual<br />

inspection with acetic acid has emerged<br />

as a satisfactory screening test to detect<br />

cervical <strong>cancer</strong> precursor lesions, with a<br />

sensitivity ranging from 67 to 90% [14,<br />

18-20]. This is similar to (or higher than)<br />

the sensitivity of cytological screening,<br />

but specificity is generally lower (range is<br />

64-92%). Therefore, if screening based on<br />

visual inspection with acetic acid is instituted,<br />

a potential consequence would be<br />

high rates of referral for further investigation.<br />

Currently, randomized intervention<br />

trials are in progress in India to evaluate<br />

the cost-effectiveness of visual inspection<br />

with acetic acid in cervical <strong>cancer</strong> screening<br />

[21].<br />

Addition of magnification to visual inspection<br />

with acetic acid has not further<br />

improved the test performance [14, 22].<br />

Cervicography involves the taking of a<br />

photograph of the acetic acid-impregnated<br />

cervix to be reviewed by trained cervicographic<br />

interpreters. Cervicography<br />

has been found to have a lower sensitivity<br />

than cervical cytology [14, 23], and also<br />

<strong>report</strong>edly suffers from high false positive<br />

rates [24].

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!